Clinical Trial Update: Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating systemic chemotherapy with lenvatinib plus sintilimab for intrahepatic cholangiocarcinoma with distant metastasis is underway but statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: ICC | Phase 2 | Status: UNKNOWN